Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 3
1947 3
1948 2
1949 9
1950 14
1951 22
1952 30
1953 42
1954 41
1955 57
1956 57
1957 63
1958 89
1959 75
1960 85
1961 74
1962 112
1963 121
1964 543
1965 717
1966 860
1967 1152
1968 1526
1969 2143
1970 2097
1971 2353
1972 2368
1973 2661
1974 2554
1975 2415
1976 2300
1977 2384
1978 2266
1979 2319
1980 2008
1981 1056
1982 331
1983 317
1984 443
1985 460
1986 482
1987 823
1988 630
1989 1001
1990 840
1991 861
1992 1004
1993 1149
1994 1345
1995 1399
1996 1608
1997 1571
1998 1585
1999 1574
2000 1709
2001 1698
2002 1939
2003 1745
2004 1773
2005 2022
2006 2071
2007 2137
2008 2133
2009 2204
2010 2316
2011 2443
2012 2460
2013 1987
2014 1596
2015 1520
2016 1809
2017 1650
2018 1533
2019 632
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

85,524 results
Results by year
Filters applied: . Clear all
Page 1
[Graft failure in allogeneic hematopoietic stem cell trans-plantation]
Cao L and Shi J. Zhejiang Da Xue Xue Bao Yi Xue Ban 2018 - Review. PMID 30900845 Chinese.
With the progress of medical technology, the development of new drugs and the improvement of the therapeutic effect of graft-versus host disease in the last two decades, the outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) have been greatly improved. ...In recent years, with the implementation of HLA haplo-identical hematopoietic stem cell transplantation, the role of donor-specific antibodies in graft failure has attracted attention increasingly. ...
With the progress of medical technology, the development of new drugs and the improvement of the therapeutic effect of graft-versus host dis …
Graft nephrectomy in children
Phillips BL and Callaghan CJ. Pediatr Nephrol 2018 - Review. PMID 28631039 Free PMC article.
Kidney transplantation is recognised as the gold standard treatment of end-stage renal disease in most children, with excellent graft survival rates. When graft failure occurs, renal transplant recipients (RTRs) have the option of removal of the transplant (graft nephrectomy [GN]), or leaving the failed transplant in situ. ...
Kidney transplantation is recognised as the gold standard treatment of end-stage renal disease in most children, with excellent graft …
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Patel SS, et al. Biol Blood Marrow Transplant 2018. PMID 29369800 Free PMC article.
Although day +100 survival among allogeneic hematopoietic cell transplantation (HCT) recipients has improved over time, longer-term survival remains a challenge. ...Of 413 patients undergoing a first allogeneic HCT between 2006 and 2014, 335 survived >100 days post-transplantation. The majority underwent a myeloablative transplantation (75%) with a bone marrow (BM) (52%) graft source. ...
Although day +100 survival among allogeneic hematopoietic cell transplantation (HCT) recipients has improved over time, longer-term s …
Surgical, ethical, and psychosocial considerations in human head transplantation.
Furr A, et al. Int J Surg 2017 - Review. PMID 28110028 Free PMC article.
Transplanting a head and brain is perhaps the final frontier of organ transplantation. The goal of body-to-head transplantation (BHT) is to sustain the life of individuals who suffer from terminal disease, but whose head and brain are healthy. ...The purpose of this target article, the complementary manuscript focused on immunological issues in BHT, and the accompanying Commentaries by scholars and practitioners in medicine, immunology, and bioethics is to review major surgical and psychosocial-ethical and immunological considerations surrounding body-to-head transplantation. ...
Transplanting a head and brain is perhaps the final frontier of organ transplantation. The goal of body-to-head transplanta
Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients
Kurtzberg J, et al. Biol Blood Marrow Transplant 2014 - Clinical Trial. PMID 24216185 Free article.
Severe steroid-refractory acute graft-versus-host disease (aGVHD) is related to significant mortality and morbidity after allogeneic stem cell transplantation. ...
Severe steroid-refractory acute graft-versus-host disease (aGVHD) is related to significant mortality and morbidity after allogeneic stem ce …
85,524 results
Jump to page
Feedback